BIOXIS Pharmaceuticals

  • News
  • Careers
  • Press
  • Contact
  • Home
  • Company
    • Strategic alliances
    • Partners
  • Technology
  • Products
    • MTI-12
  • Production & certification
  • Investors
  • Biomaterials to
    push the boundaries
    of dermatology

  • Products

    Raising the Bar
    in Aesthetic
    Dermatology

    From Groundbreaking Science to Medical Device

    Advances in biopolymer materials have revolutionized aesthetic medicine, and turned unimaginable procedures into real possibilities.

    Here at Bioxis, our proprietary technology is based on chitosan and hyaluronic acid; addressing significant, unmet medical needs in the aesthetic dermatology market. That’s why our new products are in such high demand.

  • MTI-12

    Monophasic Tissular Inductor for Aesthetic Dermatology

    The First Monophasic Tissular Inductor Able to Regenerate Neo-Tissues and Collagen

    Discover More

  • Cytosial

    Monophasic Hyaluronic Acid to Reduce the Signs of Aging

    With a Double-Level Molecular Organization that Provides Elevated Rheological Performance, Long-Lasting Effect and Safety

    Discover More

BIOXIS pharmaceuticals
317 avenue Jean Jaurès
69007 Lyon, France
  • Home
  • Company
  • Technology
  • Products
  • Production & certification
  • Investors
  • News
  • Careers
  • Press
  • Contact
  • Legal notices
Logo region Auvergne Rhone Alpes
© Bioxis pharmaceuticals - White Chapel - ID-Alizés